newsfilter
← Latest News
PR Newswire·

LogicBio Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Business Updates

–FDA lifted clinical hold on SUNRISE trial in pediatric patients with methylmalonic acidemia –Interim clinical data from Phase 1/2 trial expected to be presented by end of second quarter 2022 –LogicBio to present at ASGCT 2022 Annual Meeting